|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 950 F Street, NW |
Address2 | Suite 300 |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 31350-12
|
||||||||
|
6. House ID# 306540000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Paul J. Larsen, Deputy Compliance Officer & Assistant General Counsel |
Date | 04/20/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 1, American Recovery and Reinvestment Act of 2009: health care provisions including comparative effectiveness research, health information technology, and privacy issues
H.R. 1105, Omnibus Appropriations Act, 2009: budget for FDA and HHS
S. 1, American Recovery and Reinvestment Act of 2009: health care provisions including comparative effectiveness, health information technology, and privacy issues
S. 336, American Recovery and Reinvestment Act of 2009: health care provisions including comparative effectiveness, health information technology, and privacy issues
S.Con.Res.13, 2010 Budget Resolution: health care related provisions
H.Con.Res. 85, 2010 Budget Resolution: health care related provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Agency for Health Care Policy & Research
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Bryant |
Hall |
|
|
|
Jennifer |
Swenson |
|
Staff Assist., Legis. Correspondent, Legis. Assist., |
|
" |
" |
|
Deputy Legis. Director - Senator Pat Roberts |
|
Hallie |
Maranchick |
|
|
|
Thomas |
Moore |
|
|
|
Brian |
Nagle |
|
|
|
Heather |
Strawn |
|
|
|
Matt |
Sulkala |
|
Senior Legislative Assistant - Rep. Allen Boyd |
|
Valerie |
Jewett |
|
Legis. Director - Rep. Rodney Frelinghuysen |
|
Steve |
Tilton |
|
|
|
Michael |
Woody |
|
Professional Staff - Senate HELP Committee |
|
Maya |
Bermingham |
|
|
|
Randy |
Burkholder |
|
|
|
Andrea |
Douglas |
|
|
|
Ann |
Kaplan |
|
|
|
Mimi |
Kneuer |
|
|
|
Byron |
Patterson |
|
|
|
Lori |
Reilly |
|
|
|
Richard |
Smith |
|
|
|
Billy |
Tauzin |
|
|
|
David |
Boyer |
|
Special Assist. to the President for Legislative |
|
" |
" |
|
Affairs - White House, Assist. Comm'r for |
|
" |
" |
|
Legislation - FDA, Special Assist. for Over- |
|
" |
" |
|
sight - HHS, Special Assist. to the Secretary - |
|
" |
" |
|
HHS, Special Assist. in Office of Assist. |
|
" |
" |
|
Secretary for Legislation - HHS, Special Assist. |
|
" |
" |
|
in Office of White House Liaison - Dept. of |
|
" |
" |
|
Defense, Confidential Assist. in Office of |
|
" |
" |
|
Secretary - Dept. of Labor |
|
Jennifer |
Van Meter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
H.R. 628, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation
H.R. 1260, Patent Reform Act of 2009: reforms of the patent laws
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics
H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics
H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009: patent settlements
S. 299, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges: establishing a pilot program for district court judges concerning patent litigation
S. 369, Preserve Access to Affordable Generics Act: patent settlements
S. 515, Patent Reform Act of 2009: reforms of the patent laws
S. 560, Patent Reform Act of 2009: reforms of the patent laws
S. 610, Patent Reform Act of 2009: reforms of the patent laws
S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics, including provisions on data exclusivity and patent procedures for biologics
International intellectual property issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Patent & Trademark Office (PTO), U.S. Trade Representative (USTR), Commerce - Dept of (DOC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Billy |
Tauzin |
|
|
|
Robert |
Filippone |
|
|
|
Bryant |
Hall |
|
|
|
Hallie |
Maranchick |
|
|
|
Heather |
Strawn |
|
|
|
Matt |
Sulkala |
|
Senior Legislative Assistant - Rep. Allen Boyd |
|
Brian |
Toohey |
|
|
|
Steve |
Tilton |
|
|
|
Michael |
Woody |
|
Professional Staff - Senate HELP Committee |
|
Mimi |
Kneuer |
|
|
|
David |
Korn |
|
|
|
Kendra |
Martello |
|
|
|
Byron |
Patterson |
|
|
|
Richard |
Smith |
|
|
|
Jennifer |
Swenson |
|
Staff Assist., Legis. Correspondent, Legis. |
|
" |
" |
|
Assist., Dep. Legis. Director - Sen. Pat Roberts |
|
David |
Boyer |
|
Special Assist. to the President for Legislative |
|
" |
" |
|
Affairs - White House, Assist. Comm'r for |
|
" |
" |
|
Legislation - FDA, Special Assist. for Over- |
|
" |
" |
|
sight - HHS, Special Assist. to the Secretary - |
|
" |
" |
|
HHS, Special Assist. in Office of Assist. |
|
" |
" |
|
Secretary for Legislation - HHS, Special Assist. |
|
" |
" |
|
in Office of White House Liaison - Dept. of |
|
" |
" |
|
Defense, Confidential Assist. in Office of |
|
" |
" |
|
Secretary - Dept. of Labor |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 444, 340B Program Improvement and Integrity Act: 340B program issues
H.R. 759, Food and Drug Administration Globalization Act of 2009: import safety
H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009: importation
H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics
H.R. 1548, Pathway for Biosimilars Act, House: regulatory approval pathway for follow-on biologics
S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009: importation
S. 717, 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act: reimbursement and clinical trial issues
S. 726, Promoting Innovation and Access to Life-Saving Medicine Act: regulatory approval pathway for follow-on biologics
S. 3409, Drug and Device Accountability Act of 2008: import safety
Health care reform issues
Confirmation of Department of Health and Human Services Secretary
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Natl Economic Council (NEC), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Smith |
|
|
|
Bryant |
Hall |
|
|
|
Lauryl |
Jackson |
|
|
|
Valerie |
Jewett |
|
Legis. Director - Rep. Rodney Frelinghuysen |
|
Hallie |
Maranchick |
|
|
|
Thomas |
Moore |
|
|
|
Brian |
Nagle |
|
|
|
Heather |
Strawn |
|
|
|
Matt |
Sulkala |
|
Senior Legislative Assistant - Rep. Allen Boyd |
|
Billy |
Tauzin |
|
|
|
Steve |
Tilton |
|
|
|
Michael |
Woody |
|
Professional Staff - Senate HELP Committee |
|
Maya |
Bermingham |
|
|
|
Randy |
Burkholder |
|
|
|
Ann |
Kaplan |
|
|
|
Mimi |
Kneuer |
|
|
|
David |
Korn |
|
|
|
Kendra |
Martello |
|
|
|
Byron |
Patterson |
|
|
|
Lori |
Reilly |
|
|
|
Jennifer |
Swenson |
|
Staff Assist., Legis. Correspondent, Legis. |
|
" |
" |
|
Assist., Dep. Legis. Director - Sen. Pat Roberts |
|
David |
Boyer |
|
Special Assist. to the President for Legislative |
|
" |
" |
|
Affairs - White House, Assist. Comm'r for |
|
" |
" |
|
Legislation - FDA, Special Assist. for Over- |
|
" |
" |
|
sight - HHS, Special Assist. to the Secretary - |
|
" |
" |
|
HHS, Special Assist. in Office of Assist. |
|
" |
" |
|
Secretary for Legislation - HHS, Special Assist. |
|
" |
" |
|
in Office of White House Liaison - Dept. of |
|
" |
" |
|
Defense, Confidential Assist. in Office of |
|
" |
" |
|
Secretary - Dept. of Labor |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1, American Recovery and Reinvestment Act of 2009: Medicaid rebate
H.R. 2, Childrens Health Insurance Program Reauthorization Act of 2009: SCHIP reauthorization, Medicaid rebate, 340B
H.R. 684, Medicare Prescription Drug Savings and Choice Act: Part D issues
S. 1, American Recovery and Reinvestment Act of 2009: Medicaid rebate
S. 275, Childrens Health Insurance Reauthorization Act of 2009: SCHIP reauthorization,
Medicaid rebate
S. 301, Physician Payments Sunshine Act of 2009: transparency issues
S. 330, Medicare Prescription Drug Savings and Choice Act: Part D issues
S. 350, American Recovery and Reinvestment Act of 2009: Medicaid rebate
S. 458, False Claims Clarification Act of 2009: liability issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Agency for Health Care Policy & Research, Health & Human Services - Dept of (HHS), Congressional Budget Office (CBO), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Van Meter |
|
|
|
Bryant |
Hall |
|
|
|
Lauryl |
Jackson |
|
|
|
Hallie |
Maranchick |
|
|
|
Thomas |
Moore |
|
|
|
Heather |
Strawn |
|
|
|
Matt |
Sulkala |
|
Senior Legislative Assistant - Rep. Allen Boyd |
|
Billy |
Tauzin |
|
|
|
Steve |
Tilton |
|
|
|
Michael |
Woody |
|
Professional Staff - Senate HELP Committee |
|
Randy |
Burkholder |
|
|
|
Ann |
Kaplan |
|
|
|
Mimi |
Kneuer |
|
|
|
Byron |
Patterson |
|
|
|
Richard |
Smith |
|
|
|
Jennifer |
Swenson |
|
Staff Assist., Legis. Correspondent, Legis. |
|
" |
" |
|
Assist., Dep. Legis. Director - Sen. Pat Roberts |
|
David |
Boyer |
|
Special Assist. to the President for Legislative |
|
" |
" |
|
Affairs - White House, Assist. Comm'r for |
|
" |
" |
|
Legislation - FDA, Special Assist. for Over- |
|
" |
" |
|
sight - HHS, Special Assist. to the Secretary - |
|
" |
" |
|
HHS, Special Assist. in Office of Assist. |
|
" |
" |
|
Secretary for Legislation - HHS, Special Assist. |
|
" |
" |
|
in Office of White House Liaison - Dept. of |
|
" |
" |
|
Defense, Confidential Assist. in Office of |
|
" |
" |
|
Secretary - Dept. of Labor |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
H.R. 1, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues
S. 1, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues
S. 336, American Recovery and Reinvestment Act of 2009: trade adjustment assistance issues
Korea Free Trade Agreement: intellectual property, market access and public health
Peru Free Trade Agreement: intellectual property, market access and public health
International market access and intellectual property issues
Trade enforcement issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Commerce - Dept of (DOC), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Robert |
Filippone |
|
|
|
Thomas |
Moore |
|
|
|
Brian |
Toohey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | 950 F Street, NW, Suite 300 |
||||||
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: http://www.phrma.org/about_phrma/member_company_list/members/
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |